Concepedia

Author

Markus Ditschkowski

Essen University HospitalORCID

Also Known As

M Ditschkowski, M. Ditschkowski, Markus Ditschkowski

83

Publications

3.3K

Citations

27

H-Index

58

Concepts

All Affiliations

Essen University HospitalUniversität HamburgUniversity Medical Center Hamburg-EppendorfHeinrich Heine University DüsseldorfHeidelberg University
MD

About

Markus Ditschkowski is an author at Essen University Hospital specializing in medicine, transplantation, and cell transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

18

1.5K

2

Health Sciences

6

6

253

3

Public Health

1

1

21

4

Allergy

1

1

107

5

Biomedical Engineering

1

1

29

Markus Ditschkowski

×

35

Publications

2.7K

Citations

24

H-Index

YearCitations

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Robert Zeiser, Andreas Burchert, Claudia Lengerke,

Leukemia

2015

535

Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients

Ahmet Elmaağaclı, Nina K. Steckel, Michael Koldehoff,

Blood

2011

310

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Nimitha R. Mathew, Francis Baumgartner, Lukas M. Braun,

Nature Medicine

2018

283

HLA-DR Expression and Soluble HLA-DR Levels in Septic Patients After Trauma

Markus Ditschkowski, E. Kreuzfelder, Vera Rebmann,

Annals of Surgery

1999

189

Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis

Nicolaus Kröger, Toni Giorgino, Bart L. Scott,

Blood

2015

178

Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation

Nico Gagelmann, Markus Ditschkowski, Rashit Bogdanov,

Blood

2019

175

Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation

Markus Ditschkowski, Hermann Einsele, Rainer Schwerdtfeger,

Transplantation

2003

107

Long-term survival of sorafenib-treated FLT3-ITD–positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation

Stephan Metzelder, Thomas Schroeder, Michael Lübbert,

European Journal of Cancer

2017

68

Humoral and Cellular Vaccination Responses against SARS-CoV-2 in Hematopoietic Stem Cell Transplant Recipients

Monika Lindemann, Vesna Klisanin, Laura Thümmler,

Vaccines

2021

62

Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis

Markus Ditschkowski, AH Elmaagacli, Rudolf Trenschel,

Haematologica

2012

61

Page 1